General Information of This Drug (ID: DM3MDOL)

Drug Name
Phenazopyridine   DM3MDOL
Synonyms
phenazopyridine; Pyridiate; Gastracid; 94-78-0; Baridium; Pyrazofen; Urogesic; 3-(Phenylazo)-2,6-pyridinediamine; Geridium; Gastrotest; Viridium; 2,6-Pyridinediamine, 3-(phenylazo)-; Pyridacil; Fenazopiridina; Eridium; 2,6-Diamino-3-phenylazopyridine; Phenazopyridinum; 2,6-Diamino-3-(phenylazo)pyridine; Phenazopyridine [INN:BAN]; UNII-K2J09EMJ52; Phenazopyridinum [INN-Latin]; Fenazopiridina [INN-Spanish]; NSC 145895; HSDB 3153; EINECS 202-363-2; BRN 0184497; 3-(phenyldiazenyl)pyridine-2,6-diamine; Pyridine, 2,6-diamino-3-(phenylazo)-
Indication
Disease Entry ICD 11 Status REF
Dysuria MF50.7 Approved [1]
Pain MG30-MG3Z Approved [2]
Middle East Respiratory Syndrome (MERS) 1D64 Investigative [3]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Phenazopyridine + Methylene blue DC1FWCT Methylene blue Mild Cognitive Impairment [4]
------------------------------------------------------------------------------------

References

1 Phenazopyridine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7616).
3 High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J Virol. 2019 May 29;93(12). pii: e00023-19.
4 ClinicalTrials.gov (NCT02380573) Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease